$2.74T
Total marketcap
$131.51B
Total volume
BTC 50.39%     ETH 16.57%
Dominance

Maven Brands Inc. TLA.F Stock

0.0005 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
480.74K EUR
LOW - HIGH [24H]
0.0005 - 0.0005 EUR
VOLUME [24H]
1K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR

Maven Brands Inc. Price Chart

Maven Brands Inc. TLA.F Financial and Trading Overview

Maven Brands Inc. stock price 0.0005 EUR
Previous Close 0.02 EUR
Open 0.02 EUR
Bid 0.006 EUR x N/A
Ask 0.05 EUR x N/A
Day's Range 0.006 - 0.006 EUR
52 Week Range 0.0005 - 0.04 EUR
Volume 789 EUR
Avg. Volume 16 EUR
Market Cap 400.26K EUR
Beta (5Y Monthly) 2.390091
PE Ratio (TTM) Infinity
EPS (TTM) 0 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

TLA.F Valuation Measures

Enterprise Value 6.54M EUR
Trailing P/E Infinity
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) -70.81759
Price/Book (mrq) N/A
Enterprise Value/Revenue -1156.886
Enterprise Value/EBITDA -9.06

Trading Information

Maven Brands Inc. Stock Price History

Beta (5Y Monthly) 2.390091
52-Week Change -50.00000000000000000000000000000000%
S&P500 52-Week Change 20.43%
52 Week High 0.04 EUR
52 Week Low 0.0005 EUR
50-Day Moving Average 0.01 EUR
200-Day Moving Average 0.008465 EUR

TLA.F Share Statistics

Avg. Volume (3 month) 16 EUR
Avg. Daily Volume (10-Days) 12 EUR
Shares Outstanding 35.14M
Float 31.06M
Short Ratio N/A
% Held by Insiders 11.62%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 1:9

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End March 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 14715.07%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -9.96%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) -5652 EUR
Revenue Per Share (ttm) 0 EUR
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -721699 EUR
Net Income Avi to Common (ttm) -757634 EUR
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 41.11K EUR
Total Cash Per Share (mrq) 0.001 EUR
Total Debt (mrq) 6M EUR
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.104
Book Value Per Share (mrq) -0.05

Cash Flow Statement

Operating Cash Flow (ttm) 147.8K EUR
Levered Free Cash Flow (ttm) -529567 EUR

Profile of Maven Brands Inc.

Country Germany
State BC
City Vernon
Address 100 Kalamalka Lake Road
ZIP V1T 9G1
Phone N/A
Website https://mavenbrands.ca
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Maven Brands Inc. cultivates, processes, and sells medical cannabis. The company was formerly known as True Leaf Brands Inc. and changed its name to Maven Brands Inc. in November 2021. Maven Brands Inc. was founded in 2013 and is based in Vernon, Canada.

Q&A For Maven Brands Inc. Stock

What is a current TLA.F stock price?

Maven Brands Inc. TLA.F stock price today per share is 0.0005 EUR.

How to purchase Maven Brands Inc. stock?

You can buy TLA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Maven Brands Inc.?

The stock symbol or ticker of Maven Brands Inc. is TLA.F.

Which industry does the Maven Brands Inc. company belong to?

The Maven Brands Inc. industry is Drug Manufacturers-Specialty & Generic.

How many shares does Maven Brands Inc. have in circulation?

The max supply of Maven Brands Inc. shares is 961.47M.

What is Maven Brands Inc. Price to Earnings Ratio (PE Ratio)?

Maven Brands Inc. PE Ratio is now.

What was Maven Brands Inc. earnings per share over the trailing 12 months (TTM)?

Maven Brands Inc. EPS is 0 EUR over the trailing 12 months.

Which sector does the Maven Brands Inc. company belong to?

The Maven Brands Inc. sector is Healthcare.